{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:23:34Z","timestamp":1760549014494},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,9,25]],"date-time":"2010-09-25T00:00:00Z","timestamp":1285372800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s11095-010-0268-6","type":"journal-article","created":{"date-parts":[[2010,9,24]],"date-time":"2010-09-24T17:08:31Z","timestamp":1285348111000},"page":"2694-2703","source":"Crossref","is-referenced-by-count":28,"title":["In Vitro and In Vivo Anticancer Activity of a Novel Nano-sized Formulation Based on Self-assembling Polymers Against Pancreatic Cancer"],"prefix":"10.1007","volume":"27","author":[{"given":"Clare","family":"Hoskins","sequence":"first","affiliation":[]},{"given":"Mehdi","family":"Ouaissi","sequence":"additional","affiliation":[]},{"given":"Sofia Costa","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Woei Ping","family":"Cheng","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Loureirio","sequence":"additional","affiliation":[]},{"given":"Eric","family":"Mas","sequence":"additional","affiliation":[]},{"given":"Dominique","family":"Lombardo","sequence":"additional","affiliation":[]},{"given":"Anabela","family":"Cordeiro-da-Silva","sequence":"additional","affiliation":[]},{"given":"Ali","family":"Ouaissi","sequence":"additional","affiliation":[]},{"given":"Paul","family":"Kong Thoo Lin","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,9,25]]},"reference":[{"key":"268_CR1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jjco\/hyh045","volume":"34","author":"AB Lowenfels","year":"2004","unstructured":"Lowenfels AB, Maisonneuve P. Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol. 2004;34:238\u201344.","journal-title":"Jpn J Clin Oncol"},{"key":"268_CR2","first-page":"489","volume":"64","author":"FH Sarkar","year":"2009","unstructured":"Sarkar FH, Li Y, Wang Z, Kong D. Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chir. 2009;64:489\u2013500.","journal-title":"Minerva Chir"},{"key":"268_CR3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3322\/canjclin.52.1.23","volume":"52","author":"A Jemal","year":"2002","unstructured":"Jemal A, Thomas A, Murray T, Thun M. Cancer statistics. Cancer J Clin. 2002;52:23\u201347.","journal-title":"Cancer J Clin."},{"issue":"3","key":"268_CR4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jamcollsurg.2005.04.008","volume":"201","author":"A Sa Cunha","year":"2005","unstructured":"Sa Cunha A, Rault A, Laurent C, Adhoute X, Vendrely V, Bellannee G, et al. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas. J Am Coll Surg. 2005;201(3):359\u201365.","journal-title":"J Am Coll Surg"},{"key":"268_CR5","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1053\/j.gastro.2005.03.039","volume":"128","author":"AC Lockhart","year":"2005","unstructured":"Lockhart AC, Rothenberg ML, Berlin JD. Treatment for pancreatic cancer: current therapy and continued progress. Gastroenterology. 2005;128:1642\u201354.","journal-title":"Gastroenterology"},{"key":"268_CR6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/annonc\/mdh106","volume":"15","author":"I Novarino","year":"2004","unstructured":"Novarino I, Chiappin GF, Bertelli A, Heouaine G, Ritorto A, Addeo G, et al. Phase II study of cisplatin, gemcitabine and 5-fluorouracil in advanced pancreatic cancer. Ann Oncol. 2004;15:474\u20137.","journal-title":"Ann Oncol"},{"key":"268_CR7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bmc.2006.09.031","volume":"15","author":"J Oliveira","year":"2007","unstructured":"Oliveira J, Ralton L, Tavares J, Codeiro-da-Silva A, Bestwick C, McPherson A, et al. The synthesis and the in vitro cytotoxicity studies of bisnaphthalimidoproply polyamine derivatives against colon cancer cells and parasite Leishmania infantum. Bioorganic Med Chem. 2007;15:541\u20135.","journal-title":"Bioorganic Med Chem"},{"key":"268_CR8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bcp.2004.09.020","volume":"69","author":"A-M Dance","year":"2005","unstructured":"Dance A-M, Ralton L, Fuller Z, Milne L, Duthie S, Bestwick C, et al. Synthesis and biological activities of bisnaphthalimido polyamines derivatives: cytotoxicity, DNA binding, DNA damage and drug localization in breast cancer MCF 7 cells. Biochem Pharmacol. 2005;69:19\u201327.","journal-title":"Biochem Pharmacol"},{"key":"268_CR9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1042\/bst0310407","volume":"31","author":"P Kong Thoo Lin","year":"2003","unstructured":"Kong Thoo Lin P, Dance A-M, Bestwick C, Milne L. The biological activities of new polyamine derivatives as potential therapeutic agents. Biochem Soc Trans. 2003;31:407\u201310.","journal-title":"Biochem Soc Trans"},{"key":"268_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2008.09.033","volume":"177","author":"L Ralton","year":"2009","unstructured":"Ralton L, Bestwick CS, Milne L, Duthie S, Kong Thoo Lin P. The study of Bisnaphthalimidopropyl Spermidine and Spernine on DNA damage and repair within Colon Carcinoma Cells. Chem-Biol Interact. 2009;177:1\u20136.","journal-title":"Chem-Biol Interact"},{"key":"268_CR11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/1568011013354624","volume":"1","author":"MF Brana","year":"2001","unstructured":"Brana MF, Ramos A. Naphthalimides as anti-cancer agents: synthesis and biological activity. Curr Med Chem Anti-Canc Agents. 2001;1:237\u201355.","journal-title":"Curr Med Chem Anti-Canc Agents"},{"key":"268_CR12","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0960-894X(00)00293-6","volume":"10","author":"P Kong Thoo Lin","year":"2000","unstructured":"Kong Thoo Lin P, Pavlov VA. The synthesis and in vitro cytotoxic studies of novel Bis-naphthalimidopropyl polyamine derivatives. Bioorg Med Chem Lett. 2000;10:1609\u201312.","journal-title":"Bioorg Med Chem Lett"},{"key":"268_CR13","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00396-008-1925-8","volume":"286","author":"C Thompson","year":"2008","unstructured":"Thompson C, Ding C, Qu X, Yang Z, Uchegbu IF, Tetley L, et al. The effect of polymer architecture on the nano self-assemblies based on novel comb-shaped amphiphilic poly(allylamine). Colloid Polym Sci. 2008;286:1511\u201326.","journal-title":"Colloid Polym Sci"},{"key":"268_CR14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1517\/13543776.17.7.819","volume":"17","author":"L Qiu","year":"2007","unstructured":"Qiu L, Zheng C, Jin Y, Zhu K. Polymeric micelles as nanocarriers for drug delivery. Expert Opin Ther Pat. 2007;17:819\u201330.","journal-title":"Expert Opin Ther Pat"},{"key":"268_CR15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.actbio.2008.09.018","volume":"5","author":"MC Branco","year":"2009","unstructured":"Branco MC, Schneider JP. Self-assembling materials for therapeutic delivery. Acta Biomaterialia. 2009;5:817\u20133.","journal-title":"Acta Biomaterialia"},{"key":"268_CR16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejpb.2006.11.009","volume":"65","author":"K Letchford","year":"2007","unstructured":"Letchford K, Burt H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm. 2007;65:259\u201369.","journal-title":"Eur J Pharm Biopharm"},{"key":"268_CR17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.pharmthera.2006.05.006","volume":"112","author":"N Nishiyama","year":"2006","unstructured":"Nishiyama N, Kataoka K. Current state, achievements and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther. 2006;112:630\u201348.","journal-title":"Pharmacol Ther"},{"key":"268_CR18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0169-409X(96)00401-2","volume":"21","author":"G Kwon","year":"1996","unstructured":"Kwon G, Okano T. Polymeric micelles as new drug carriers. Adv Drug Deliv Rev. 1996;21:107\u201316.","journal-title":"Adv Drug Deliv Rev"},{"key":"268_CR19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1517\/13543776.17.7.819","volume":"17","author":"L Qui","year":"2007","unstructured":"Qui L, Zheng C, Jin Y, Zhu K. Polymeric micelles as nanocarriers for drug delivery. Expert Opin Ther Pat. 2007;17:819\u201330.","journal-title":"Expert Opin Ther Pat"},{"key":"268_CR20","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/bm060130l","volume":"7","author":"WP Cheng","year":"2006","unstructured":"Cheng WP, Gray AI, Tetley L, Hang TLB, Sch\u00e4tzlein AG, Uchegbu IF. Polyelectrolyte nanoparticles with high drug loading enhance the oral uptake of hydrophobic compounds. Biomacromolecules. 2006;7:1509\u201320.","journal-title":"Biomacromolecules"},{"key":"268_CR21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0169-409X(95)00031-2","volume":"16","author":"G Kwon","year":"1995","unstructured":"Kwon G, Kataoka K. Block Copolymer micelles as long-circulating drug vehicles. Adv Drug Deliv Rev. 1995;16:295\u2013309.","journal-title":"Adv Drug Deliv Rev"},{"key":"268_CR22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2008.02.003","volume":"128","author":"H-Y Hwang","year":"2008","unstructured":"Hwang H-Y, Kim I-S, Kwon IC, Kim Y-H. Tumour targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release. 2008;128:23\u201331.","journal-title":"J Control Release"},{"key":"268_CR23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-200363060-00005","volume":"63","author":"F Albaaj","year":"2003","unstructured":"Albaaj F, Hutchison AJ. Hyperphosphataemia in renal failure: causes, consequences and current management. Drugs. 2003;63:577\u201396.","journal-title":"Drugs"},{"key":"268_CR24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1021\/bc9900439","volume":"10","author":"O Boussif","year":"1999","unstructured":"Boussif O, Delair T, Brua C, Veron L, Pavirani A, Kolbe HVJ. Synthesis of polyallylamine derivatives and their use as gene transfer vectors in vitro. Bioconjug Chem. 1999;10:877\u201383.","journal-title":"Bioconjug Chem"},{"key":"268_CR25","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1016\/j.biomaterials.2010.01.116","volume":"31","author":"YC Chung","year":"2010","unstructured":"Chung YC, Hsieh WY, Young TH. Polycation\/DNA complexes coated with oligonucleotides for gene delivery. Biomaterials. 2010;31:4194\u2013203.","journal-title":"Biomaterials"},{"key":"268_CR26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1773-2247(09)50084-6","volume":"19","author":"C Vigl","year":"2009","unstructured":"Vigl C, Leithner K, Albrecht K, Bernkop-Schnurch A. The effluc pump inhibitory properties of (thiolated) polyallylamines. J Drug Deliv Sci Technol. 2009;19:405\u201311.","journal-title":"J Drug Deliv Sci Technol"},{"key":"268_CR27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0006-3495(99)77214-0","volume":"76","author":"RC Scaduto Jr","year":"1999","unstructured":"Scaduto Jr RC, Grotyohann LW. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J. 1999;76:469\u201377.","journal-title":"Biophys J"},{"key":"268_CR28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","volume":"139","author":"I Nicoletti","year":"1991","unstructured":"Nicoletti I, Migliorati G, Pagliacei MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991;139:271\u20139.","journal-title":"J Immunol Methods"},{"key":"268_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1432-1327.1998.2520001.x","volume":"252","author":"B Mignotte","year":"1998","unstructured":"Mignotte B, Vayssiere JL. Mitochondria and apoptosis. Eur J Biochem. 1998;252:1\u201315.","journal-title":"Eur J Biochem"},{"key":"268_CR30","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","volume":"15","author":"HA Burris","year":"1997","unstructured":"Burris HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15:2403\u201313.","journal-title":"J Clin Oncol"},{"key":"268_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1443-9573.2007.00314.x","volume":"9","author":"G Wichert von","year":"2008","unstructured":"von Wichert G, Seufferlein T, Adler G. Palliative treatment of pancreatic cancer. J Dig Dis. 2008;9:1\u20137.","journal-title":"J Dig Dis"},{"key":"268_CR32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.seminoncol.2007.05.009","volume":"34","author":"EM O\u2019Reilly","year":"2007","unstructured":"O\u2019Reilly EM, Abou-Alfa GK. Cytotoxic therapy for advanced pancreatic adenocarcinoma. Semin Oncol. 2007;34:347\u201353.","journal-title":"Semin Oncol"},{"key":"268_CR33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1634\/theoncologist.2007-0134","volume":"13","author":"H Burris","year":"2008","unstructured":"Burris H, Rocha-Lima III C. New therapeutic directions for advanced pancreatic cancer: targeting the epidermal growth factor and vascular endothelial growth factor pathways. Oncologist. 2008;13:289\u201398.","journal-title":"Oncologist"},{"key":"268_CR34","first-page":"1509","volume":"25","author":"S Mei","year":"2004","unstructured":"Mei S, Ho AD, Mahlknecht U. Role of histone deacetylase inhibitors in the treatment of cancer. Int J Oncol. 2004;25:1509\u201319.","journal-title":"Int J Oncol"},{"key":"268_CR35","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1158\/1535-7163.MCT-04-0186","volume":"4","author":"P Garcia-Morales","year":"2005","unstructured":"Garcia-Morales P, Gomez-Martinez A, Carrato A, Martinez-Lacaci I, Barbera VM, Soto JL, et al. Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines. Mol Cancer Ther. 2005;4:1222\u201330.","journal-title":"Mol Cancer Ther"},{"key":"268_CR36","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bbamcr.2007.05.002","volume":"1773","author":"M Donadelli","year":"2007","unstructured":"Donadelli M, Costanzo C, Beghelli S, Scupoli MT, Dandrea M, Bonora A, et al. Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine. Biochim Biophys Acta. 2007;1773:1095\u2013106.","journal-title":"Biochim Biophys Acta"},{"key":"268_CR37","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.bbrc.2006.07.185","volume":"348","author":"J Bai","year":"2006","unstructured":"Bai J, Demirjian A, Sui J, Marasc W, Callery MP. Histone deacetylase trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells. Biochim Biophys Res Comm. 2006;348:1245\u201353.","journal-title":"Biochim Biophys Res Comm"},{"key":"268_CR38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4161\/cbt.7.4.5480","volume":"7","author":"M Oua\u00efssi","year":"2008","unstructured":"Oua\u00efssi M, Cabral S, Tavares J, Cordeiro da Silva A, Mathieu-Daude F, Mas E, et al. Histone deacetylase (HDAC) encoding gene expression in pancreatic cancer cell lines and cell sensitivity to HDAC inhibitors. Cancer Biol Ther. 2008;7:523\u201331.","journal-title":"Cancer Biol Ther"},{"key":"268_CR39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/cmdc.200900367","volume":"5","author":"J Tavares","year":"2010","unstructured":"Tavares J, Ouaissi A, Kong Thoo Lin P, Loureiro I, Kaur S, Roy N, et al. Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1. ChemMedChem. 2010;5:140\u20137.","journal-title":"ChemMedChem"},{"key":"268_CR40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2008.01.007","volume":"127","author":"P Chytil","year":"2008","unstructured":"Chytil P, Etrych T, Konak C, Sirova M, Mrkvan T, Boucek J, et al. New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting. J Control Release. 2008;127:121\u201330.","journal-title":"J Control Release"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-010-0268-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-010-0268-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-010-0268-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:54:03Z","timestamp":1559368443000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-010-0268-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,25]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["268"],"URL":"https:\/\/doi.org\/10.1007\/s11095-010-0268-6","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,25]]}}}